• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

SPACE-H Accelerator to Explore Astronaut Disease Treatment in Space

by Syed Hamza Sohail 09/27/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know:

–  NaNotics LLC, a biopharmaceutical company developing NaNots® – novel subtractive nanoparticles that treat disease by capturing and clearing pathogenic molecules from blood – today announced that it has been selected for the inaugural SPACE-H Accelerator program – a collaboration between Starburst, NASA’s Human Research Program (NASA HRP), the Translational Research Institute for Space Health (TRISH), Methuselah Foundation, and Microsoft Federal.

–  The SPACE-H mission is “to support entrepreneurs working to advance biological and medical capabilities with the potential to minimize the health and performance risks in human spaceflight.”

NaNotics: Pioneering Soluble Target Therapies for Oncology, Inflammatory Diseases, and Space Health Challenges

NaNotics LLC, a late preclinical-stage company based in Mill Valley, CA, is developing a cutting-edge pipeline of NaNots®, targeting soluble molecules that drive a range of oncology and inflammatory diseases with significant unmet medical needs. NaNots are engineered to specifically target soluble molecules dissolved in blood, and uniquely differentiate between biochemically identical soluble and membrane-bound targets—offering superior performance over traditional antibody therapies.

NaNots present a novel therapeutic approach by adsorbing disease-driving molecules from the bloodstream. Notably, profound tumor suppression has been demonstrated by Mayo Clinic studies using NaNots in a humanized mouse model of triple-negative breast cancer, a type that typically responds poorly to conventional drugs. Additionally, NaNots have shown efficacy in extinguishing deadly cytokine storms by rapidly adsorbing inflammatory molecules responsible for these immune overreactions.

With increasing interest in long-duration space exploration, NaNots offer a potential breakthrough in addressing health challenges posed by the harsh space environment. Factors such as accelerated aging and disease emergence require innovative treatment options. NaNots are particularly well-suited for space applications due to their ease of use—they can be administered via simple injection, with depletion of disease-driving molecules confirmed using portable blood analyzers. This makes them a valuable option for programs like NASA’s Artemis, which aims to establish a permanent lunar base, and other space missions where traditional medical technologies are impractical due to size, weight, and operational complexity.

By addressing both earthbound diseases and space-specific health challenges, NaNotics is positioned to advance the next generation of autonomous healthcare solutions.

“We’re very excited to have been selected for the first cohort of the SPACE-H program,” said Lou Hawthorne, CEO of NaNotics and the inventor of NaNots®. “The SPACE-H program is run by some of the world’s top technologists; their interest in our work speaks to the advanced nature of the NaNot platform and its potential significance for maintaining health in space as well as on Earth.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

Evernorth Health Services Invests $3.5B in Shields Health Solutions

Evernorth Health Services Invests $3.5B in Shields Health Solutions

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

M&A:Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

Femtech: Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

Healthcare C-Suite Acknowledges AI Potential but Lacks Trust

Sage Growth Partners Report: Healthcare C-Suite Acknowledges AI Potential but Lacks Trust

EVERSANA and Waltz Health Merge to Redefine Pharmaceutical Commercialization

EVERSANA and Waltz Health Merge to Redefine Pharmaceutical Commercialization

Advancing Diabetes Care: Combating Burnout and Harnessing Technology

Advancing Diabetes Care: Combating Burnout and Harnessing Technology

White House Event Unveils CMS Health Tech Ecosystem Initiative

White House Event Unveils CMS Health Tech Ecosystem Initiative

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |